Evolve CSO to speak at the North American Microbiome Congress
Evolve BioSystems is pleased to announce that our Chief Scientific Officer, Dr. David Kyle, will be speaking at the 3rd Annual North American MIcrobiome Congress in San Diego, CA on February 6th.
Dr. Kyle will be presenting our latest research on the infant gut microbiome, in a talk titled "Providing and Maintaining a Healthy Microbiome in All Infants During the First 6 Months of Life."
The 3rd Annual North America Microbiome Congress in San Diego has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.
For more details on the event, click here
Evolve BioSystems Contact
Dr. Tracy Shafizadeh
Director, Scientific Communications
About Evolve BioSystems
Evolve BioSystems, Inc. is a privately-held microbiome company dedicated to developing the next generation of products to establish, restore, and maintain a healthy human gut microbiome. Evolve is a spin-out from the Foods for Health Institute (FFHI) at the University of California, Davis and builds on more than a decade of research into understanding the unique partnership of the infant gut microbiome and breast milk components. Having led to the discovery and development of products to resolve infant gut dysbiosis, Evolve’s discovery platform is now being applied to solving gut dysbiosis throughout the human life cycle as well as in various animal species. Evolve has now successfully completed a milestone proof-of-concept study to demonstrate the efficacy of its initial proprietary offering. In addition, Evolve is undertaking further clinical studies to build out its offering of microbiome-based solutions across a spectrum of unmet clinical needs.